Jonathan Avery
Overview
Explore the profile of Jonathan Avery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Devaraja K, Avery J, Iyengar Y, Zhang Y, Climans S
Neurooncol Pract
. 2025 Feb;
12(1):143-152.
PMID: 39917753
Background: Primary central nervous system (CNS) tumors significantly affect individuals globally, with patients in Ontario, Canada, often bearing financial burdens for treatments such as oral chemotherapy due to insufficient coverage,...
2.
Lamarche J, Nissim R, Avery J, Wong J, Maheu C, Lambert S, et al.
Psychooncology
. 2025 Jan;
34(2):e70084.
PMID: 39887474
Objective: Fear of cancer recurrence (FCR) is common, persistent, and associated with lower quality of life, impaired functioning, and psychological distress in family caregivers (FC) of individuals with a cancer...
3.
Lamarche J, Nissim R, Avery J, Wong J, Maheu C, Lambert S, et al.
Pilot Feasibility Stud
. 2024 Nov;
10(1):143.
PMID: 39563465
Background: Fear of cancer recurrence (FCR) is common, persistent, and is associated with lower quality of life, impaired functioning, and psychological distress in cancer patients. Studies suggest that family caregivers...
4.
Baig Z, Appel G, Verzani Z, Abramson E, Safdieh J, Kang Y, et al.
Prim Care Companion CNS Disord
. 2024 May;
26(3).
PMID: 38815267
No abstract available.
5.
Balmuth E, Iyer S, Scales D, Avery J
J Gen Intern Med
. 2024 May;
39(11):2087-2096.
PMID: 38698295
Background: Individuals with substance use disorders (SUDs) are hospitalized in growing numbers. Stigma is pervasive among their hospital providers, and SUD management during medical admissions is often inadequate. However, little...
6.
Avery J, Bell J, Baryolay K, Rodin G, Nissim R, Balneaves L
BMC Cancer
. 2024 Mar;
24(1):373.
PMID: 38528488
Background: Participants considering early-phase cancer clinical trials (CTs) need to understand the unique risks and benefits prior to providing informed consent. This qualitative study explored the factors that influence patients'...
7.
Woods M, Appel G, Daulbayeva A, Harris C, Picard R, Iyasere J, et al.
Acad Psychiatry
. 2023 Nov;
48(1):110-111.
PMID: 37957428
No abstract available.
8.
Smith M, Korenblum C, Mosher P, Gupta A, Avery J
J Adolesc Young Adult Oncol
. 2023 Nov;
13(2):239-241.
PMID: 37930835
No abstract available.
9.
Avery J, Campbell K, Mosher P, Al-Awamer A, Goddard K, Edwards A, et al.
Qual Health Res
. 2023 Oct;
34(1-2):72-85.
PMID: 37844970
Young adults (YAs), defined as individuals between the ages of 18 and 39 years, experience unique challenges when diagnosed with advanced cancer. Using the social constructivist grounded theory approach, we...
10.
Vekaria V, Patra B, Xi W, Murphy S, Avery J, Olfson M, et al.
J Subst Use Addict Treat
. 2023 Oct;
156:209177.
PMID: 37820869
Introduction: Prior literature establishes noteworthy relationships between suicidal symptoms and substance use disorders (SUDs), particularly opioid use disorder (OUD). However, engagement with health care services among this vulnerable population remains...